Growing Consumption of Probiotics to Boost Demand for Yeast Extract and Beta Glucan

Transparency Market Research (TMR) estimates that the global yeast extract and beta glucan market is anticipated to register robust growth in the near future. Yeasts display highly diverse nature in different conditions and find applications in various industries such as processed foods and functional foods and pharmaceuticals. Thus, there is a high adoption of yeast extract and beta glucan in these industries. They are used in households as well to formulate them into different types of products. For instance, vegemite, a source of yeast, is used from home brew alcohol production in many parts of the Australian continent.

View exclusive Global strategic Business report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1484

As per a new study by TMR, the global yeast extract and beta glucan market stood at US$677.6 mn in 2015 and is anticipated to rise to US$1,054.5 mn by the end of 2021, expanding at a CAGR of 7.6% between 2015 and 2021.

How is food and beverage industry influencing the growth of the global yeast extract and beta glucan market?

The augmented use of yeast extract and beta glucan in processed foods and functional foods owing to the growing popularity of probiotic functional food among consumers is boosting the growth of the global yeast extract and beta glucan market. Yeast extracts find applications as flavoring ingredients in the brewing and baking sector. Also, the use of nutritional dietary supplements, industrial ethanol, and probiotics as natural catalysts is boosting the growth of the global yeast extract and beta glucan market. Moreover, the surging demand for fuel has led to the extensive usage of cellulosic biofuels, which are obtained from yeast extract. Thus, the increasing demand for yeast extract and beta glucan is propelling the growth of the global yeast extract and beta glucan market.

Why is the demand for yeast extract and beta glucan from the pharmaceutical industry increasing exponentially?

The adoption of yeast extract and beta glucan in pharmaceuticals is also likely to increase manifolds in the forthcoming year. Yeast beta glucan is gaining prominence in the pharmaceutical sector owing to its ability to manage high cholesterol and diabetes and boosting immunity. Due to the growing prevalence of cancer, yeast beta glucan is largely used in preventing radiation-related injury. It also finds a place in the prevention of pathogenic infections and sepsis caused by surgery. In recent times, clinical advancements have boosted the growth of the global yeast extract and beta glucan market. To put this in perspective, in August 2016, a team of researchers at the U.S. Department of Energy Joint Genome Institute (DOE JGI) mapped various metabolic pathways to yeast growth profiles that will improve its biotech uses in the coming years.

The manufacturers operating in the global yeast extract and beta glucan market are likely to avail untapped opportunities in sectors such as cosmetics, beverages, and dietary supplements. This factor is anticipated to bolster the growth of the global yeast extract and beta glucan market.

What are the trends observed across various regions in the global yeast extract and beta glucan market?

In terms of geography, Europe was the leading regional market in 2015 and is anticipated to retain its leadership by 2021. The impressive growth of the food and beverage industry coupled with the growing awareness about the health benefits of yeast beta glucan is driving the Europe market. Most of the demand in this region comes from leading markets such as the UK and France. The Europe yeast extracts and beta glucan market is anticipated to expand at a CAGR of 7.5% from 2015 to 2021. Asia Pacific and North America are expected to exhibit noteworthy growth rate during the same period. However, the continuous shortages of molasses are likely to deter the growth of the global yeast extract and beta glucan market.